Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0JN3M
|
||||
Former ID |
DIB006987
|
||||
Drug Name |
ITAMELINE
|
||||
Synonyms |
RU-47213; Itameline < Rec INN >; (E)-3-[(Methoxyimino)methyl]-1,2,5,6-tetrahydropyridine-1-carboxylic acid 4-chlorophenyl ester
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Cognitive disorders [ICD9: 290-294, 294.0, 780.09, 780.9, 780.93; ICD10:F01-F07, F04, F05, R41.3] | Discontinued in Phase 1 | [545662] | ||
Structure |
Download2D MOL |
||||
Formula |
C14H15ClN2O3
|
||||
Canonical SMILES |
CO\\N=C\\C1=CCCN(C1)C(=O)Oc2ccc(Cl)cc2
|
||||
InChI |
1S/C14H15ClN2O3/c1-19-16-9-11-3-2-8-17(10-11)14(18)20-13-6-4-12(15)5-7-13/h3-7,9H,2,8,10H2,1H3/b16-9+
|
||||
InChIKey |
CTVQNEVLCGSTKL-CXUHLZMHSA-N
|
||||
CAS Number |
CAS 121750-57-0
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Muscarinic acetylcholine receptor M1 | Target Info | Agonist | [551871] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.